1007 Maintenance bacillus Calmette-Guerin immunotherapy for TaG3 or T1G3 and/or carcinoma in situ transitional cell carcinoma of the bladder: Final results of the randomized CUETO Group Study 98013.

Authors :: Martínez-Piñeiro, L.
Hernández, R.
Portillo, J.A.
Fernández, J.M.
Zabala, J.A.
Cadierno, I.
Moyano, J.L.
Solsona, E.
Unda, M.
Rodríguez-Molina, J.
Beardo, P.
Palou, J.
Muntañola, P.
Pérez-Garcia, F.J.
Silva, J.M.
Chesa, N.
Montesinos, M.
Ojea, A.
Source :: European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe1007-e1007a. 0p.
Publication Year :: 2014

Full Text Access

Tools